BioSpace News Archive

Acquisition Expands Cosmetic Surgery Services in Miami-Dade and Broward Counties for Water’s Edge

DUOBRII is the first and only topical lotion that contains a unique combination of halobetasol propionate and tazarotene in one formulation.

Compound Designed to Enhance Synaptic Integrity and Improve Learning, Memory and Function

Provides immediate scale and profitability to AbbVie’s growth platform, excluding Humira, significantly expanding and diversifying its revenue base with new therapeutic areas, including Allergan’s leading medical aesthetics business

Service enables synthesis of DNA sequences up to 200kb with 100 percent sequence accuracy

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this Summer to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research

Soliton, Inc., a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, announced that the company has retained Emergent Clinical Consulting, LLC to serve as the Company’s Contract Research Organization and manage its upcoming pivotal Cellulite Trial.

Lifestyle Delivery Systems Inc.,, is pleased to announce that the City of Adelanto, where the Company’s state-of-the-art facilities are located, is hosting a Cannabis Job Fair on June 25, 2019, and CannaStrips™ is one of the sponsors.

Actinium Pharmaceuticals, Inc. announced at SNMMI or the 2019 Society of Nuclear Medicine and Molecular Imaging Annual Meeting that effective lymphodepletion with the radioisotope Lu-177 or lutetium-177 was achieved with its ACT or Adoptive Cell Therapy program for achieving safe, effective and transient lymphodepletion prior to the administration of CAR-T and other adoptive cell therapies.

Federal district court finds in favor of ExeGi and probiotic inventor, prohibits VSL#3 sellers from citing studies on original formulation